
Jammu & Kashmir Bank Q2 Results 2025 Highlights: Net Profit Plunged by 10.47% & Revenue Up 0.76% YoY
Posted by : sachet | Wed Oct 22 2025

Click and Sign Up to Get Live Updates on Q2 Results
Jammu & Kashmir Bank revealed its Q2 results on 18th October 2025. In Q2 FY26, revenue increased 0.76% YoY, and profit decreased 10.47% YoY. The company posted substantial numbers, with Q2 PAT at ₹494.92 crores and revenue of ₹3,450.26 crores.
Jammu & Kashmir Bank Q2 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)
Particulars | Quarter Ended | |
30th Sep 2025 | 30 Sept 2024 | |
Revenue from Operations | ₹3,450.26 | ₹3,424.31 |
Profit Before Tax (PBT) | – | – |
Profit After Tax (PAT) | ₹494.92 | ₹552.78 |
(Figures in crores)
Central Bnak of India Q2 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)
Particulars | Quarter Ended | |
30th Sep 2025 | 30 Sept 2024 | |
Revenue from Operations | ₹3,446.71 | ₹3,419.63 |
Profit Before Tax (PBT) | – | – |
Profit After Tax (PAT) | ₹494.11 | ₹550.92 |
(Figures in crores)
Jammu & Kashmir Bank Q2 Results FY26 Highlights (Q2 FY26 vs FY25)
- Jammu & Kashmir Bank clocked Q2 FY26 consolidated revenue of ₹3,450.26 crores, up from ₹3,424.31 crores.
- On the profit front, Jammu & Kashmir Bank earned a consolidated PAT of ₹494.92 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹552.78 crore.
- According to the consolidated figures, Jammu & Kashmir Bank’s quarterly PAT decreased by 10.47% YoY, while revenue increased by 0.76%.
- Jammu & Kashmir Bank clocked Q2 FY26 standalone revenue of ₹3,446.71 crores vs ₹3,41.63 crores.
- On the profit front, Jammu & Kashmir Bank earned a standalone PAT of ₹494.11 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹550.92 crore.
- According to the standalone figures, Jammu & Kashmir Bank’s quarterly PAT decreased by 10.31% YoY, while revenue increased by 0.79% YoY.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Jammu & Kashmir Bank Share Price Performance
Jammu & Kashmir Bank shares have a 52-week high of 117.25 and a 52-week low of 86.61. The market capitalisation is ₹11,816 crore. According to some reports, the share price is currently downward sloping. The P/E Ratio of the Jammu & Kashmir Bank stock is 5.65. Jammu & Kashmir Bank shares have delivered returns of 1.38% over the past month and -1.11% over the past six months. Over the past year, Jammu & Kashmir Bank’s shares returned 13.35% to investors.
What Analysts Expect Post Q2 Results?
Jammu & Kashmir Bank’s strong Q2 results for FY26 have led analysts to expect its share price to trend higher in the coming years. According to analysts, the bank’s share price could reach ₹110.78 per share in the upcoming year and, in a downside scenario, hit ₹108.78 per share. However, one must ignore stock market volatility and invest in the bank’s shares after thorough research.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Recent Articles
Nestle Q2 Results FY26: Q2 PAT Falls 17.38% to ₹743.17 Crore; Revenue Up 10.57% YoY
Inspira Enterprise India IPO Details: Everything You Should Know about
Swaraj Engines Q2 Results FY26: Q2 PAT Rises 8.88% to ₹49 Crore; Revenue Up 8.62% YoY
HDB Financial Q2 Results FY26: Q2 PAT Falls 1.5% to ₹581 Crore; Revenue Up 13.42% YoY
BEL Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here
Paytm Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here
Blue Dart Gears Up for Q2 Reveal on 28th October; Check Key Expectations Here
Related Posts
Federal Bank Q2 Results 2025 Highlights: Net Profit Falls by 9.52% & Revenue Up 3.82% YoY
Induslnd Bank Q2 Results 2025 Highlights: Net Profit plunged by 132.82% & Revenue Up 10.84% YoY
IDFC First Bank Q2 Results 2025 Highlights: Net Profit Surged by 64.10% & Revenue Up 10.71% YoY
Yes Bank Q2 Results 2025 Highlights: Net Profit Rises by 17.25% & Revenue Down 1.22% YoY
Shreeji Global FMCG IPO GMP & Review: Should You Apply or Avoid?
